Résultats de recherche

Effectuez une recherche ici pour trouver ce que vous cherchez.  Si vous cherchez un produit de Teva, effectuez une recherche dans l’un de nos catalogues de produits ou n’hésitez pas à communiquer avec nous pour assistance.  

Affichage des résultats 9 sur 9

Government Tour of Teva Canada’s Stouffville Manufacturing Facility Showcases Pharmaceutical Capabilities and Underscores Economic Value to Canada

Important Safety Information on Nicotine Patches

Toronto, Ontario (February 7, 2024) - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., is proud to announce that it has been named to Forbes list of Canada’s Best Employers 2024. Teva Canada ranked No. 1 of Drugs & Biotechnology employers and No. 28 of 300 overall employers.

Government Tour of Teva Canada’s Stouffville Manufacturing Facility Showcases Pharmaceutical Capabilities and Underscores Economic Value to Canada

Important Safety Information on Codeine Antitussive Products

Important safety information on prescription cough and cold products containing opioids and the risk of opioid ase disorder in children and adolescents

Teva Canada secures Salbutamol Inhalers from its global supply chain to mitigate shortage in Canadian market

Teva Canada announces the launch of AJOVY™ for the preventive treatment of migraine in adults who have at least four migraine days per month

Teva Canada announces the Approval of HERZUMA®, a biosimilar to HERCEPTIN® for the treatment of adult patients with Early Breast Cancer, Metastatic Breast Cancer and Metastatic Gastric Cancer.
This is the second Notice of Compliance (NOC) issued for a biosimilar in 2019 that Teva Canada Innovation will add to its portfolio of brands, generics and biosimilars.